StonvexLoading…
StonvexStonvexStonvexCore line items from LXU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $615.21M | $522.40M | $593.71M | $901.71M |
Operating Income | $57.27M | $-5.50M | $51.78M | $308.38M |
Net Income | $24.61M | $-19.35M | $27.92M | $230.35M |
EPS (Diluted) | $0.34 | $-0.27 | $0.37 | $2.68 |
Total Assets | $1.17B | $1.19B | $1.30B | $1.44B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $19.51M | $20.23M | $98.50M | $63.77M |
Free Cash Flow OCF − CapEx | $18.06M | $-5.72M | $69.92M | $299.82M |
Shares Outstanding | 72.36M | 71.97M | 75.10M | 86.03M |